Avinger Completes Enrollment in SCAN Clinical Study
August 23, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has...
Avinger Announces Second Quarter 2018 Financial Results
August 13, 2018 16:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the...
Avinger to Report Second Quarter 2018 Results on Monday, August 13, 2018
August 06, 2018 10:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), will announce its second...
Avinger Announces Pricing of $3.55 Million Registered Direct Offering
July 12, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has...
Avinger Appoints Jaafer Golzar, MD, FACC, FSCAI, as Chief Medical Officer
July 10, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the...
Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris in Several Centers throughout the US
June 26, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that several...
Avinger’s Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018
June 21, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Ocelot...
Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound
June 14, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the initiation...
Avinger Appoints Mark Weinswig as Chief Financial Officer
June 13, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD),...
Avinger Announces Presentations and Posters Featuring Lumivascular Technology at New Cardiovascular Horizons Annual Conference
May 30, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...